Tag: research

As part of the Cancer Tech Accelerator, we’ve awarded Neurolase £50,000 to advance a laser-based tool that could help make brain tumour surgery more precise.

Artificial intelligence (AI) could help better inform treatment planning for meningioma, our researchers have found.

We’re breaking down common clinical trial myths to celebrate International Clinical Trials Day (20 May).

Emma Neason explains why she decided to join our Lay Advisory Board – a group of people with lived experience of brain tumours who help inform our research funding decisions.

We are funding two ambitious new pilot studies designed to spark progress in how we diagnose, monitor and treat brain tumours.

In a positive end to Brain Tumour Awareness Month 2026, we are pleased that NICE has approved vorasidenib to treat some types of brain tumours.

Our researchers are marking a significant step towards a blood test for glioblastoma.

We’re delighted to share the news that vorasidenib has been approved by the Scottish Medicines Consortium to treat some low grade gliomas.

Over a decade ago, The Brain Tumour Charity funded research exploring new ways to stop glioblastoma cells from invading healthy brain tissue. The project built a thriving research community that continues to drive progress today.

We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!

This International Day of Women and Girls in Science, we sat down with Dr Verónica Rendo, who was funded by The Brain Tumour Charity’s Future Leaders scheme in 2020.

We are so grateful to the Trustees and supporters of Iggy’s Fund for the £30,000 donation towards Professor Maya Thanou’s research into a new technology called ActNano. 

We’re proud to be funding Access to Clinical Trials for Brain Tumours (ACT-BT), a UK-wide initiative that will enable consultants to refer patients to a panel of clinical trial experts.

Our Future Leader, Dr Chris Mount, has just opened his own lab at Massachusetts General Hospital.

Find out what a clinical research nurse does, from empowering patients to guiding them through complex treatment options – all to drive medical breakthroughs.

We’ve sent your feedback to the consultation on NICE’s draft guidance on vorasidenib. These are just some of the powerful testimonies we received that formed part of that.

We are pleased to announce that we have awarded £3 million to two new, exciting research projects!

New research suggests that immune cells in low grade gliomas may help them survive, providing insight that could lead to new treatments for children with these tumours.

Despite the disappointing draft guidance published by NICE, there’s still hope that vorasidenib will be available through the NHS in England.

Researchers have pinpointed a new biomarker that could help doctors more accurately predict the behaviour of meningiomas.

For the first time, The Brain Tumour Charity has collaborated with the Grace Kelly Childhood Cancer Trust as a funding partner, investing nearly £50,000 into research on paediatric brain tumours.

Future Leader Dr Ángel Álvarez-Prado has discovered that blocking a particular protein can both reduce GBM cells’ ability to multiply and kickstart the immune system.

We’re excited to announce our investment of nearly £1.2 million into new translational research projects that aim to speed up the journey from lab discoveries to clinical treatment.

We brought together our Future Leaders, supporters who help to fund them, and volunteers with lived experience of brain tumours.